Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TG-interacting factor 1 improves risk stratification in patients with NPM1-mutated acute myeloid leukemia.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Jul 2023

Tang Hongwei, Zhang Nan, Li Huan, Chen Ying, Liu Xinlei, Xiao Hongbo, Deng Jianchuan, Zhou Kang

Abstract excerpt

BACKGROUND: Acute myeloid leukemia (AML) is a heterogeneous disease characterized by diverse genetic abnormalities. The NPM1 is the most commonly mutated gene in newly diagnosed patients. Optimizing risk stratification in this population could facilitate more rational clinical decision-making. OBJECTIVES: To identify biomarkers that optimize risk stratification in AML patients with NPM1 mutations. MATERIAL AND...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Homeodomain Proteins
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Nuclear Proteins

Share to Nucleophosmin

Share to Prognosis

Share to Repressor Proteins

Share to Risk Assessment

Source

Identifiers

PMID: 36753372
DOI: 10.17219/acem/157478

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TG-interacting factor 1 improves risk stratification in patients with NPM1-mutated acute myeloid leukemia.PMID 36753372Read ↗

Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia.Semantic proximity Read ↗

Targeted therapy in NPM1-mutated AML: Knowns and unknownsSemantic proximity Read ↗

Genomics-based Approach and Prognostic Stratification Significance of Gene Mutations in Intermediate-risk Acute Myeloid Leukemia.Semantic proximity Read ↗

MiR-10a-5p regulates proliferation, apoptosis and cell cycle of NPM1-mutated acute myeloid leukemia cells by targeting SHANK3Semantic proximity Read ↗

A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

<i>TG-Interacting Factor 1</i> expression quantitatively impacts survival in acute myeloid leukemiaSemantic proximity Read ↗

PLA2G4A Is a Potential Biomarker Predicting Shorter Overall Survival in Patients with Non-M3/ NPM1 Wildtype Acute Myeloid LeukemiaSemantic proximity Read ↗

Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.Semantic proximity Read ↗

FLT3-ITD-associated gene-expression signatures in NPM1-mutated cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 Expression.Semantic proximity Read ↗

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt-related transcription factor 1 mutation: A single-center retrospective analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.